Logiscreen

Harrow Inc

$33.19
Market Cap 1.24B
ROE -33.7%
Gross Margin 61.2%
Debt/Equity 10.5
Current Ratio 2.5
Revenue QoQ -7.6%
EPS QoQ 0.5%
F-Score 3

About

Harrow, Inc. is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non‑prescription pharmaceutical products accessible and affordable to millions of patients each year.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-86.32
vs median 31.50
P/B
44.99
vs median 2.17
ROE
-0.34
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics